SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2055Thanks. And you are correct about the P2 data. It won't be out until July.fred hayes-2/4/2008
2054<i>4 separate one thousand patient studies underway. You must be aware of Clarksterh-2/4/2008
2053Yup, I know. Just trying to bait you into some commentary (:>). Maybe I'fred hayes-2/4/2008
2052I intentionally mentioned "small molecule" programs in my response, exscaram(o)uche-2/4/2008
2051>> If there some MTD that I haven't yet found << Nope. Just Hoscaram(o)uche-2/4/2008
2050You and Rick are way out of my league here, but I'm surprised no mention of fred hayes-2/4/2008
2049<i>Just because other trials suck, Myriad's looks good?</i> TheClarksterh-2/4/2008
2048>> do you know of an AD trial you like better << In the small molecscaram(o)uche-2/4/2008
2047Thanks for the answer. <i>That phase II trial that failed to meet endpoinClarksterh-2/3/2008
2046>> Their Alzheimer's drug program has more promise than any other Iscaram(o)uche-2/3/2008
2045scaram - You obviously don't think too much of MYGN management. Perhaps youClarksterh-2/3/2008
2044<i>Decision Resources, one of the world's leading research and advisorClarksterh-2/3/2008
2043Myriad Genetics Announces Completion of Phase 1 Trial of Anti-Thrombin Drug MPC-sim1-1/29/2008
2042Drug Markets in Cognitive Dysfunction Will Experience Dramatic Transformation asLJM-1/15/2008
2041i cant help but think selling the may 55's or 60's call on half the posimopgcw-1/14/2008
2040update of pipeline page..... prolexys.comscaram(o)uche-1/6/2008
2039Forbes: Myriad's Momentum John Dobosz 12.13.07, 11:30 AM ET Joseph Parnesmopgcw-12/18/2007
2038exothermic destruction of timelines. while it took eons longer than Peter prediscaram(o)uche-12/11/2007
2037Is this global warming? :)kenhott-12/7/2007
2036Hell froze. (eom)scaram(o)uche-12/5/2007
2035Myriad Genetics Submits IND on Vivecon Novel Mechanism of Action, Active Againssim1-12/4/2007
2034Cervical cancer screening news Any possibility for this HPV testing to be provisim1-10/18/2007
2033Myriad Shares Fall on Cowen Concerns Thursday October 11, 1:07 pm ET Myriad GA.J. Mullen-10/11/2007
2032Congrads to the holders. Look at that price line go!kenhott-10/2/2007
2031Retrospect is a wonderful thing. I knew that! I'm good at no-brainers. (I dtom pope-10/1/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News